Leht 1 alates 22 tulemused
INTRODUCTION
The present invention relates to sterols, their fatty acid esters and glucosides; to processes for their preparation; to spontaneously dispersible agents containing these compounds, and to their use for treatment of tumours.
Surprisingly, it has been found that mainly the sterols
FIELD OF THE INVENTION
The present invention relates to a composition containing a selective estrogen receptor modulator and at least one isoflavone, and a method of treating breast cancer while inhibiting selective estrogen receptor modulator induced uterotrophic effects.
BACKGROUND OF THE
This application relates to treatment of cancer and in particular provides a method of inhibiting the growth of tumors (cancer) cells by blocking glucose transport across the cell membrane.
Many cancer cells are characterized by their excessive glycolysis of glucose whereby glucose is converted to
FIELD OF THE INVENTION
The present invention relates to the use of purified limonoin glucoside for the treatment of chronic inflammatory diseases.
BACKGROUND OF THE INVENTION
Circulating concentrations of the hepatic enzymes gamma glutamyl transferase (GGT), alanine amino transferase (ALT), alkaline
This invention relates to compositions extracted from vegetable matter and more particularly to phytochemicals, including saponogenins and saponins, lignans, phenolic acids, catechins and isoflavones, and especially those extracted from a family of plants including soy, flax, tea, and cocoa and
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to dimeric epipodophyllotoxin glucoside derivatives, to their therapeutic anti-tumor use, and to pharmaceutical dosage forms containing these new agents.
2. Description of the Related Art
Etoposide (VP-16, Ia) and
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to novel nitrogen containing derivatives of epipodophyllotoxin glucoside derivatives, to their therapeutic anti-tumor use, and to pharmaceutical dosage forms containing these new agents.
2. Description of the Related
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to 3'-demethoxy epipodophyllotoxin glucoside derivatives, to their therapeutic anti-tumor use, and to pharmaceutical dosage forms containing these new agents.
2. Description of the Related Art
Etoposide (VP-16, Ia)
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed to novel 4'-deshydroxyepipodophyllotoxin glucosides, to methods of preparing these new compounds, and to the therapeutic use of the compounds in inhibiting the growth of mammalian tumors.
2. Description of the
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is directed to new epipodophyllotoxin glucoside derivatives, to methods of preparing these new derivatives, and to the therapeutic use of these new derivatives. More particularly, this invention is directed to oxidized derivatives
BACKGROUND OF THE INVENTION
This invention relates to 1,4-bis-(substituted aminoalkylamino)-anthraquinones, and more particularly to the same as anti-neoplastic agents against animal neoplasms. 1,4-bis-substituted anthraquinones have long been known in the prior art as dyes. For example, U.S. Pat.
BACKGROUND OF THE INVENTION
Breast cancer kills thousands of women annually. While surgical intervention has saved the lives of many women, radical and partial mastectomies often prove physically and emotionally debilitating. Indeed, surgery, even when combined with chemotherapy, may still expose
BACKGROUND OF THE INVENTION
Breast cancer kills thousands of women annually. While surgical intervention has saved the lives of many women, radical and partial mastectomies often prove physically and emotionally debilitating. Indeed, surgery, even when combined with chemotherapy, may still expose
BACKGROUND OF THE INVENTION
The invention relates to novel extracts obtained by extraction of ripe complete soya beans or from oil-free soya flour (Glycine max (L.) MERRIL, Leguminosae family), their production and formulations containing these extracts. The novel extracts are characterized by their
BACKGROUND OF THE INVENTION
The invention relates to novel extracts obtained by extraction of ripe complete soya beans or from oil-free soya flour (Glycine max (L.) MERRIL, Leguminosae family), their production and formulations containing these extracts. The novel extracts are characterized by their